ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers.
Positioning changes implemented during the latest selloff proved beneficial as equities staged a powerful first-quarter rebound.
ClearBridge is engaging companies in the drug value chain to better control opioid distribution and develop therapeutic alternatives to opioids.
We are closely monitoring potential regulatory and legislative developments in the technology and health care sectors as well as signs that we are entering the later stages of the economic cycle.